Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase.

Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase.
复制标题

底物外域对底物偏好和抑制γ-分泌酶至关重要。

DOI:
10.1038/ncomms3529
复制
发表时间:
2013
影响因子:
16.6
通讯作者:
Ihara, Yasuo
Ihara, Yasuo
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Funamoto, Satoru;Sasaki, Toru;Ishihara, Seiko;Nobuhara, Mika;Nakano, Masaki;Watanabe-Takahashi, Miho;Saito, Takashi;Kakuda, Nobuto;Miyasaka, Tomohiro;Nishikawa, Kiyotaka;Saido, Takaomi C.;Ihara, Yasuo

文献摘要

参考文献

被引文献

相似文献

了解γ-分泌酶的底物识别机制是建立底物特异性抑制淀粉样蛋白β (a β)产生的关键步骤。然而,人们普遍认为γ-分泌酶是一种混杂的蛋白酶,其底物特异性抑制是难以捉摸的。我们发现γ-分泌酶能够区分底物的外畴长度,并优先捕获和切割含有短外畴的底物。我们还发现含有CDCYCxxxxCxCxSC基序的肽亚群与C99的氨基末端结合,并以底物特异性的方式抑制a β的产生。有趣的是,这些肽抑制β-分泌酶依赖性的APP裂解,但不抑制唾液基转移酶1。最重要的是,小鼠腹腔内注射多肽可显著降低大脑a β水平。本报告为γ-分泌酶的底物偏好及其机制提供了直接证据。我们的研究结果表明,C99的外畴是抗阿尔茨海默病的底物特异性抗β治疗的有效靶点。γ-分泌酶抑制剂被研究用于治疗阿尔茨海默病的潜力,但其使用受到副作用的限制。Funamoto等人表明,γ-分泌酶优先切割具有短外结构域的底物,并且基于这些外结构域的抑制剂可减少小鼠的疾病样病理。
Understanding the substrate recognition mechanism of γ-secretase is a key step for establishing substrate-specific inhibition of amyloid β-protein (Aβ) production. However, it is widely believed that γ-secretase is a promiscuous protease and that its substrate-specific inhibition is elusive. Here we show that γ-secretase distinguishes the ectodomain length of substrates and preferentially captures and cleaves substrates containing a short ectodomain. We also show that a subset of peptides containing the CDCYCxxxxCxCxSC motif binds to the amino terminus of C99 and inhibits Aβ production in a substrate-specific manner. Interestingly, these peptides suppress β-secretase-dependent cleavage of APP, but not that of sialyltransferase 1. Most importantly, intraperitoneal administration of peptides into mice results in a significant reduction in cerebral Aβ levels. This report provides direct evidence of the substrate preference of γ-secretase and its mechanism. Our results demonstrate that the ectodomain of C99 is a potent target for substrate-specific anti-Aβ therapeutics to combat Alzheimer’s disease. γ-Secretase inhibitors are studied for their potential to treat Alzheimer’s disease, but their use is limited by side effects. Funamoto et al. show that γ-secretase preferentially cleaves substrates with short ectodomains and that inhibitors based on these ectodomains reduce disease-like pathology in mice.
DOI: 10.1021/bi049399k
发表时间: 2004-10-26
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
Funamoto, S;Morshima-Kawashima, M;Ihara, Y
通讯作者: Ihara, Y
DOI: 10.1038/nm1235
发表时间: 2005-05-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Kukar, T;Murphy, MP;Golde, TE
通讯作者: Golde, TE
DOI: 10.1038/34910
发表时间: 1998-01-22
期刊: NATURE
影响因子: 64.8
作者:
De Strooper, B;Saftig, P;Van Leuven, F
通讯作者: Van Leuven, F
DOI: 10.1002/ana.22343
发表时间: 2011-06
影响因子: 11.2
作者:
Hata, Saori;Fujishige, Sayaka;Araki, Yoichi;Taniguchi, Miyako;Urakami, Katsuya;Peskind, Elaine;Akatsu, Hiroyasu;Araseki, Masahiko;Yamamoto, Kazuo;Martins, Ralph N.;Maeda, Masahiro;Nishimura, Masaki;Levey, Allan;Chung, Kathryn A.;Montine, Thomas;Leverenz, James;Fagan, Anne;Goate, Alison;Bateman, Randall;Holtzman, David M.;Yamamoto, Tohru;Nakaya, Tadashi;Gandy, Sam;Suzuki, Toshiharu
通讯作者: Suzuki, Toshiharu
DOI: 10.1074/jbc.m109.057497
发表时间: 2009-12-25
影响因子: 4.8
作者:
Hata, Saori;Fujishige, Sayaka;Suzuki, Toshiharu
通讯作者: Suzuki, Toshiharu